PUBLISHER: The Business Research Company | PRODUCT CODE: 1947070
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947070
Respiratory devices and equipment in the therapeutic category are essential for treating patients with acute or chronic respiratory disorders, including conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, and sleep disorders.
The primary products within the respiratory devices and equipment (therapeutic) market encompass nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, capnographs, and gas analyzers. Nebulizers, for instance, are small devices that convert liquid medicine into a mist, which is then inhaled by patients through a connected mouthpiece. Various technologies are employed in these respiratory devices and equipment, including HEPA filters, electrostatic filtration, microsphere separation, hollow fiber filtration, and other filtration methods. The market for these therapeutic devices is segmented based on end-users, with applications in both home care settings and hospitals.
Tariffs are impacting the respiratory devices and equipment (therapeutic) market by increasing costs of imported sensors, compressors, electronic control units, filters, and precision components used in ventilators, oxygen concentrators, and positive airway pressure devices. Hospitals and homecare providers in North America and Europe are most affected due to reliance on imported medical-grade components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising procurement costs and extending replacement cycles for healthcare facilities. However, they are also encouraging domestic manufacturing, regional supplier development, and increased investment in locally assembled respiratory care equipment.
The respiratory devices and equipment (therapeutic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (therapeutic) market statistics, including respiratory devices and equipment (therapeutic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic) market share, detailed respiratory devices and equipment (therapeutic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic) industry. This respiratory devices and equipment (therapeutic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory devices and equipment (therapeutic) market size has grown strongly in recent years. It will grow from $23.68 billion in 2025 to $25.59 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of chronic respiratory diseases, rising hospital admissions for respiratory disorders, expansion of homecare medical equipment usage, availability of advanced ventilator technologies, growth in aging population.
The respiratory devices and equipment (therapeutic) market size is expected to see strong growth in the next few years. It will grow to $35.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring solutions, rising adoption of home-based respiratory care, growing investments in smart medical devices, expansion of telehealth-supported respiratory therapies, increasing focus on early disease management. Major trends in the forecast period include increasing adoption of connected respiratory devices, rising demand for portable and homecare respiratory equipment, growing integration of smart monitoring features, expansion of non-invasive ventilation technologies, enhanced focus on patient-centric device design.
The growing number of smokers is expected to drive the expansion of the respiratory devices and equipment (therapeutic) market in the coming years. Smokers are individuals who consume tobacco products such as cigarettes, cigars, or pipes. Therapeutic respiratory devices and equipment, including inhalers and nebulizers, are used by smokers to help manage respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, and lung cancer. For example, in March 2024, according to Statistics Canada, the total number of cigarettes sold in Canada reached 1.1 billion, representing a 24.0% decline compared with March 2023. Therefore, the increasing number of smokers is contributing to the growth of the respiratory devices and equipment (therapeutic) market.
Major companies operating in the respiratory devices and equipment (therapeutic) market are concentrating on product innovation, such as the VitaloPFT series, to deliver reliable solutions to customers. The VitaloPFT series is used as respiratory devices and equipment (therapeutic) to efficiently and effectively diagnose, monitor, and manage patients' respiratory health. For example, in March 2023, Vitalograph Ltd., a UK-based manufacturer of respiratory medical devices, launched the VitaloPFT series. The VitaloPFT series is designed to provide advanced respiratory diagnostic solutions to hospitals and other secondary care facilities that require complex pulmonary function testing. The series includes the VitaloROV+, a portable pulmonary function testing (PFT) device that enables accurate point-of-care testing for patients.
In April 2024, Clario, a US-based healthcare company, acquired ArtiQ for an undisclosed amount. Through this acquisition, Clario enhanced its Respiratory Solutions portfolio by integrating scalable AI technology to improve data quality, streamline clinical trials, and expand its global reach, enabling broader applications beyond respiratory care. ArtiQ is a Belgium-based healthcare company focused on improving diagnostic and monitoring equipment for respiratory conditions.
Major companies operating in the respiratory devices and equipment (therapeutic) market are Hamilton Medical AG, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Philips Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Dragerwerk AG & Co. KGaA, Medtronic plc, Masimo Corporation, CareFusion Corporation, Getinge AB, Hill-Rom Holdings Inc., Becton Dickinson and Company, Air Liquide S.A., Vyaire Medical Inc., Compumedics Limited, Covidien plc, Mindray Medical International Limited, Inogen Inc., Nihon Kohden Corporation, Siemens Healthcare GmbH, Teleflex Incorporated, Breas Medical AB, AirSep Corporation, Rotech Healthcare Inc., 3B Medical Inc.
Asia-Pacific was the largest region in the respiratory devices and equipment (therapeutic) market in 2025. Western Europe was the second-largest region in the respiratory devices and equipment (therapeutic) market. The regions covered in the respiratory devices and equipment (therapeutic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory devices and equipment (therapeutic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The respiratory devices and equipment (therapeutic) market consist of sales of instruments such as nebulizers, oxygen concentrators, positive airway pressure devices, ventilators, inhalers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Devices And Equipment (Therapeutic) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory devices and equipment (therapeutic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory devices and equipment (therapeutic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (therapeutic) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.